Interactions between pseudoephedrine and Ergomar (ergotamine)
ergotamine and pseudoephedrine (Moderate Drug-Drug)
MANAGEMENT: The use of dihydroergotamine injection or nasal spray with vasoconstrictive agents is not recommended and other ergot alkaloids should be administered with caution. Clinical monitoring of patients response and tolerance, including measurements of vital signs and monitoring for excessive vasoconstriction, is recommended if these products are used in combination. Patients should be advised to notify their doctor if they experience numbness, tingling, or cyanosis in the extremities, muscle pains, weakness, or chest pain or tightness.








